Buzzagogo's Allergy Bee Gone for Kids nasal swab is an unapproved new drug contaminated with Bacillus bacteria.
What happened
FDA reviewed Buzzagogo's website in August 2022 and found claims showing "Allergy Bee Gone for Kids" is intended as a drug; no FDA-approved application was in effect. FDA laboratory analysis of lot 2006491 found Bacillus contamination, including B. cereus, in a nasal swab product directed for young children. After a May 24, 2022 teleconference, the company recalled that lot on June 7, 2022.
What FDA found
The product is an unapproved new drug because its labeling claims it treats allergy and cold symptoms, but no FDA-approved application is in effect.
sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)The labeling claims make it a drug intended to treat disease or affect body structure or function.
section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)It is a new drug not generally recognized as safe and effective for its labeled uses.
section 201(p) of the FD&C Act, 21 U.S.C. 321(p)Lot 2006491 was adulterated because it contained Bacillus contamination, including B. cereus, described as a filthy, putrid, or decomposed substance.
section 501(a)(1) of the FD&C Act, 21 U.S.C. 351(a)(1)Introducing or delivering the product into interstate commerce violates the FD&C Act.
section 301 of the FD&C Act, 21 U.S.C. 331
What FDA wants
FDA asks the company to provide a written response within 15 working days, including contract manufacturer names and addresses, an independent manufacturing assessment, a microbial risk assessment, batch investigations, microbial release specifications, test methods, and retain-sample results. If corrective action cannot be completed in that time, the company must explain why and give a completion date.
Who should pay attention
- brands selling children's nasal or homeopathic drug products
- contract manufacturers and testing labs for nasal drugs
- retailers and distributors handling recalled lots
This is a summary. Read the original letter on fda.gov.